Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years
Year: 2003
Type: article
DOI: 10.4088/jcp.v64n0904
Authors: Peter D. Feldman, Christopher J. Kaiser, John S. Kennedy, Virginia K. Sutton, Pierre V. Tran, Gary D. Tollefson, Fan Zhang, Alan Breier
Institution: Eli Lilly (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2056221533
